CClinicalTrials.gg
CompletedNCT00221598Updated Jan 5, 2023

Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency

An interventional study of Haemodialysis with different dialysate temperatures in Acute Renal Failure and Chronic Renal Failure, sponsored by University Hospital, Ghent. Completed at 1 site in Belgium. Open to participants aged 21 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-01-05.

Sponsored by University Hospital, Ghent · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jun 2005, registered Sep 2005).
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
21 Years to 90 Years
Sex
All
01

Study summary

Comparison between dialysate temperatures on haemodynamic stability and haemodialysis efficiency.

Read the detailed description

Comparison of 4 different dialysate temperatures for haemodialysis of patients with chronic renal failure.

Comparison of 3 different dialysate temperatures for haemodialysis of patients with acute renal failure.

Investigation of the efficiency of haemodialysis of patients with acute renal failure

02

Conditions studied

  • Acute Renal Failure
  • Chronic Renal Failure
03

In context

Renal Insufficiency

1,995 studies on the registry are indexed under Renal Insufficiency; 173 are open to participants now.

This study's enrollment of 10 is below the median of 43 across 1,504 interventional studies indexed under Renal Insufficiency.

Browse Renal Insufficiency studies →

Lead sponsor

University Hospital, Ghent is the lead sponsor of 665 studies on the registry; 156 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Chronic renal failure
  • Acute renal failure
  • Aged between 21-90 years

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    hemodialysis

    Procedure: Haemodialysis with different dialysate temperatures

Interventions

  • ProcedureHaemodialysis with different dialysate temperatures

    Haemodialysis with different dialysate temperatures is used.

06

What researchers measure

Primary outcomes

  1. Haemodynamic stability and tolerance

    Time frame: t0

07

Study locations

1 site
  • University Hospital Ghent
    Ghent, 9000, Belgium
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00221598
Lead sponsor
University Hospital, Ghent
Responsible party
Sponsor
First posted
Sep 22, 2005
Start date
Jun 2005
Primary completion
Dec 14, 2010
Completion
Dec 14, 2010
Last update
Jan 5, 2023

Study contacts

Annemieke Dhondt, MD, PhD
principal investigator · University Hospital, Ghent

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion